🇺🇸 FDA
Patent

US 11974989

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

granted A61KA61K31/426A61K38/28

Quick answer

US patent 11974989 (Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs) held by VTV THERAPEUTICS LLC expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VTV THERAPEUTICS LLC
Grant date
Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/426, A61K38/28, A61K45/06, A61K9/0053